Have a feature idea you'd love to see implemented?
Let us know!
BIO Bio-Rad Laboratories Inc
Price (delayed)
$331.78
Market cap
$9.25B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$47.34
Enterprise value
$10.23B
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley,
Highlights
The company's quick ratio rose by 12% YoY but it fell by 6% QoQ
The equity has contracted by 25% from the previous quarter and by 20% YoY
The revenue has contracted by 7% YoY
Key stats
What are the main financial stats of BIO
Market
Valuations
Earnings
Shares outstanding
27.87M
Market cap
$9.25B
Enterprise value
$10.23B
Price to book (P/B)
1.4
Price to sales (P/S)
3.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.99
Revenue
$2.56B
EBIT
-$1.68B
EBITDA
-$1.68B
Free cash flow
$177.69M
Per share
Balance sheet
Liquidity
EPS
-$47.34
Free cash flow per share
$6.26
Book value per share
$237.65
Revenue per share
$90.25
TBVPS
$315.87
Total assets
$9.69B
Total liabilities
$2.91B
Debt
$1.39B
Equity
$6.78B
Working capital
$2.57B
Debt to equity
0.21
Current ratio
6.28
Quick ratio
4.25
Net debt/EBITDA
-0.59
Margins
Efficiency
Dividend
EBITDA margin
-65.6%
Gross margin
54%
Net margin
-51.7%
Operating margin
13%
Return on assets
-11.4%
Return on equity
-16.1%
Return on invested capital
-14.8%
Return on capital employed
-18.3%
Return on sales
-65.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BIO stock price
How has the Bio-Rad Laboratories stock price performed over time
Intraday
0.04%
1 week
-0.98%
1 month
-0.84%
1 year
23.17%
YTD
2.75%
QTD
-0.84%
Financial performance
How have Bio-Rad Laboratories's revenue and profit performed over time
Revenue
$2.56B
Gross profit
$1.38B
Operating income
$332.47M
Net income
-$1.33B
Gross margin
54%
Net margin
-51.7%
BIO's operating income is down by 9% year-on-year but it is up by 3.7% since the previous quarter
The revenue has contracted by 7% YoY
Bio-Rad Laboratories's gross profit has decreased by 7% YoY
BIO's operating margin is up by 6% since the previous quarter
Growth
What is Bio-Rad Laboratories's growth rate over time
Valuation
What is Bio-Rad Laboratories stock price valuation
P/E
N/A
P/B
1.4
P/S
3.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.99
BIO's P/B is 27% above its last 4 quarters average of 1.1 but 7% below its 5-year quarterly average of 1.5
The equity has contracted by 25% from the previous quarter and by 20% YoY
The stock's price to sales (P/S) is 29% less than its 5-year quarterly average of 5.2 but 5% more than its last 4 quarters average of 3.5
The revenue has contracted by 7% YoY
Efficiency
How efficient is Bio-Rad Laboratories business performance
Dividends
What is BIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BIO.
Financial health
How did Bio-Rad Laboratories financials performed over time
The total assets has declined by 23% since the previous quarter and by 19% year-on-year
BIO's total liabilities is down by 18% since the previous quarter and by 18% year-on-year
The debt is 79% smaller than the equity
Bio-Rad Laboratories's debt to equity has increased by 40% from the previous quarter and by 31% YoY
The equity has contracted by 25% from the previous quarter and by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.